Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Perl, S; Zweiker, D; Niederl, E; Kolesnik, E; Zweiker, G; Kraler, E; Stoff, I; Haberfeld, H; Dichtl, W; Koppelstätter, C; Lhotta, K; Ederer, H; Putz-Bankutti, C; Beaney, T; Xia, X; Poulter, NR; Weber, T.
May Measurement Month 2017: an analysis of blood pressure screening results in Austria-Europe.
Eur Heart J Suppl. 2019; 21(Suppl D): D17-D20.
Doi: 10.1093/eurheartj/suz053
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Perl Sabine
- Co-Autor*innen der Med Uni Graz
-
Kolesnik Ewald
-
Niederl Ella
-
Zweiker David
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Elevated blood pressure (BP) is a growing burden worldwide, leading to over 10 million deaths each year. May Measurement Month (MMM) is a global initiative aimed at raising awareness of high BP and to act as a temporary solution to the lack of screening programs worldwide. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in May 2017. Blood pressure measurement, the definition of hypertension (HTN), and statistical analysis followed the standard MMM protocol. In total, 2711 individuals (58.6% female) were screened during MMM17 in 56 centres. After multiple imputation, 1704 (62.9%) had HTN (≥140/90 mmHg). Of individuals not receiving antihypertensive medication, 764 (43.2%) were hypertensive. Of individuals receiving antihypertensive medication, 597 (63.5%) had uncontrolled BP. MMM17 was one of the largest BP screening campaigns undertaken in Austria. A large number of undiagnosed hypertensives was found and connected to a therapeutic strategy. An alarming number of uncontrolled but treated hypertensives should attract the attention of doctors and health care system in Austria.